Nerve conduction block by nitric oxide that is mediated by the axonal environment

Journal of Neurophysiology

Volumn 79, Issue 2, 1998, Pages 529-536

  Shrager, Peter ^a   Custer, Andrew W ^a   Kazarinova, Katia ^a   Rasband, Matthew N ^a   Mattson, David ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLAMINE; NITRIC OXIDE; SODIUM CHANNEL; THIOL DERIVATIVE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; INFLAMMATORY DISEASE; NERVE CONDUCTION; NERVE GROWTH; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

EID: 0031930472     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1998.79.2.529     Document Type: Article

References (37)

1. ALLEVA, D. G., BURGER, C. J., AND ELGERT, K. D. Tumor induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. J. Immunol. 153: 1674-1686, 1994.
2. 2+ in vascular smooth muscle by inhibition of the calcium current. Cell Calcium 15: 122-131, 1994.
3. Bo, L., DAWSON, T. M., WESSELINGH, S., MORK, S., CHOI, S., KONG, P. A., HANLEY, D., AND TRAPP, B. D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36: 778-786, 1994.
4. BOLOTINA, V. M., NAJIBI, S., PALACINO, J. J., PAGANO, P. J., AND COHEN, R. A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994.
5. BOULTON, C. L., IRVING, A. J., SOUTHAM, E., POTIER, B., GARTHWAITE, J., AND COLLINGRIDGE, G. L. The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur. J. Neurosci. 6: 1528-1535, 1994.
6. 2+ current inhibition in rat sympathetic neurons. J. Physiol. (Lond.) 482: 521-531, 1995.
7. COLQUHOUN, D. AND RITCHIE, J. M. The interaction at equilibrium between tetrodotoxin and mammalian non-myelinated nerve fibres. J. Physiol. (Lond.) 221: 533-553, 1972.
8. DAWSON, T. M., DAWSON, V. L., AND SNYDER, S. H. A novel neuronal messenger molecule in brain: the free radical nitric oxide. Ann. Neurol. 32: 297-311, 1992.
9. DAWSON, V. L., DAWSON, T. M., BARTLEY, D. A., UHL, G. R., AND SNYDER, S. H. Mechanism of nitric oxide mediated neurotoxicity in primary brain cultures. J. Neurosci. 13: 2651-2661, 1993.
10. ERICINSKA, M., NELSON, D., AND VANDERKOOI, J. M. Effects of NO generating compounds on synaptosomal energy metabolism. J. Neurochem. 65: 2699-2705, 1995.
11. GARTHWAITE, J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14: 60-67, 1991.
12. GREEN, L. C., WAGNER, D. A., GLOGOWSKI, J., SKIPPER, P. L., WISHNOK, J. S., AND TANNENBAUM, S. R. Analysis of nitrate, nitrite, and 15N-nitrate in biological fluids. Anal. Biochem. 126: 131-138, 1982.
13. HOFFMAN, R. A., LANGREHR, J. M., WREN, S. M., DULL, K. E., ILDSTAD, S. T., MCCARTHY, S. A., AND SIMMONS, R. L. Characterization of the immunosuppressive effects of nitric oxide in graft vs. host disease. J. Immunol. 151: 1508-1518, 1993.
14. HRABIE, J. A., KLOSE, J. R., WINK, D. A., AND KEEPER, L. K. New nitric oxide releasing zwitterions derived from polyamines. J. Org. Chem. 58: 1472-1476, 1993.
15. IGNARRO, L. J., BUGA, G. M., WOOD, K. S., AND BYRNS, R. E. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84: 9265-9269, 1987.
16. JIA, L., BONAVENTURA, C., BONAVENTURA, J., AND STAMLER, J. S. S-nitro-sohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380: 221-226, 1996.
17. LEI, S. Z., PAN, Z. H., AGGARWAL, S. K., CHEN, H.S.V., HARTMAN, J., SUCHER, N. J., AND LIPTON, S. A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8: 1087-1099, 1992.
18. LIN, R. F., LIN, T. S., TILTON, R. G., AND CROSS, A. H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178: 643-648, 1993.
19. LIPTON, S. A., CHOI, Y. B., PAN, Z. H., LEI, S. Z., CHEN, H.S.V., SUCHER, N. J., LOSCALZO, J., SINGEL, D. J., AND STAMLER, J. S. A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds. Nature 364: 626-632, 1993.
20. MALINSKI, T., TAHA, Z., GRUNFELD, S., PATTON, S., KAPTURCZAK, M., AND TOMBOULIAN, P. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem. Biophys. Res. Commun. 193: 1076-1082, 1993.
21. MERRILL, J. E., IGNARRO, L. J., SHERMAN, M. P., MELINEK, J., AND LANE, T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151: 2132-2141, 1993.
22. MITROVIC, B., IGNARRO, L. J., MONTESTRUQUE, S., SMOLL, A., AND MERRILL, J. E. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61: 575-585, 1994.
23. MOORE, W. J. Chemical kinetics. In: Physical Chemistry. Englewood Cliffs, NJ: Prentice-Hall, 1962, p. 253-322.
24. MYERS, P. R., MINOR, R.L.J., GUERRA, R. J., BATES, J. N., AND HARRISON, D. G. Vasorelaxant properties of the endothelium derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163, 1990.
25. PALMER, R.M.J., FERRIGE, A. G., AND MONCADA, S. Nitric oxide release accounts for the biological activity of endothelium relaxing factor. Nature 327: 524-526, 1987.
26. PETERS, A., PALAY, S. L., AND WEBSTER, H. D. The Fine Structure of the Nervous System. New York: Oxford Univ. Press, 1991.
27. RADI, R., BECKMAN, J. S., BUSH, K. M., AND FREEMAN, B. A. Peroxynitrite oxidation of sulfhydryls. J. Biol. Chem. 266: 4244-4250, 1991.
28. ROED, A. Effects of the sulphydryl inhibitor N-ethyl-maleimide on the phrenic nerve and diaphragm muscle of the rat. Neuropharmacology 28: 765-773, 1989.
29. SHRAGER, P. Slow sodium inactivation in nerve after exposure to sulhydryl blocking reagents. J. Gen. Physiol. 69: 183-202, 1977.
30. STAMLER, J. S. S-nitrosothiols: correlation of biological chemistry with physiological actions. In: Biochemical, Pharmacological, and Clinical Aspects of Nitric Oxide, edited by B. A. Weissman, N. Allon, and S. Shapira. New York: Plenum, 1995, p. 67-78.
31. STAMLER, J. S. A radical vascular connection. Nature 380: 108-111, 1996.
32. STAMLER, J. S., SINGEL, D. J., AND LOSCALZO, J. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992.
33. STARKUS, J. G. AND SHRAGER, P. Modification of slow sodium inactivation in nerve after internal perfusion with trypsin. Am. J. Physiol. 235 (Cell Physiol. 4): C238-C244, 1978.
34. 2 and endothelium dependent cerebral arteriolar dilation. Hypertension 16: 162-169, 1990.
35. WOOD, J. AND GARTHWAITE, J. Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology 33: 1235-1244, 1994.
36. WU, M., PRITCHARD, K. A., KAMINSKI, P. M., FAYNGERSH, R. P., HINTZE, T. H., AND WOLIN, M. S. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2108-H2113, 1994.
37. ZIELASEK, J., JUNG, S., GOLD, R., LIEW, F. Y., TOYKA, K. V., AND HARTUNG, H. P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58: 81-88, 1995.